In vivo efficacy of SDZ 35-682, a new picornavirus capsid-binding agent
- 31 January 1995
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 26 (1) , 55-64
- https://doi.org/10.1016/0166-3542(94)00065-g
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activityAntimicrobial Agents and Chemotherapy, 1992
- Human rhinovirus 14 complexed with antiviral compound R 61837Journal of Molecular Biology, 1991
- An Appraisal of the Efficacy of the Antiviral R 61837 in Rhinovirus Infections in Human VolunteersAntiviral Chemistry and Chemotherapy, 1990
- Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837)Antimicrobial Agents and Chemotherapy, 1989
- Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilizationArchiv für die gesamte Virusforschung, 1989
- Structural analysis of antiviral agents that interact with the capsid of human rhinovirusesProteins-Structure Function and Bioinformatics, 1989
- In vitro activity of R 61837, a new antirhinovirus compoundArchiv für die gesamte Virusforschung, 1988
- A ‘new’ generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactionsAntiviral Research, 1987
- [[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoatingJournal of Medicinal Chemistry, 1985
- The Common Cold: Control?The Journal of Infectious Diseases, 1984